| Literature DB >> 28761330 |
Desmond D Mascarenhas1,2, David N Herndon3, Istvan Arany4.
Abstract
AIM: Nephrilin peptide, a designed inhibitor of Rictor complex (mTORC2), exerts pleiotropic protective effects in metabolic, xenobiotic and traumatic stress models. Stress can generate enduring epigenetic changes in gene function. In this work we examine the possibility that nephrilin treatment protects against acute and enduring global changes in oxidative metabolism, with a focus on the Rictor-complex-mediated activation of Rac1, a subunit of NADPH oxidase (Nox) via PKCs, Prex1 and p66shc.Entities:
Keywords: 8-isoprostane; Rac1; Rictor; burn injury; epigenetic; nephrilin
Year: 2017 PMID: 28761330 PMCID: PMC5522666 DOI: 10.2147/BTT.S136188
Source DB: PubMed Journal: Biologics ISSN: 1177-5475
Figure 1Fibroblasts were grown and challenged with either UV-A (uv subscript) or H2O2 (ox subscript) and cell viability and collagen I synthesis measured as described in Methods. Values are averages of triplicate assays and are expressed relative to control (=100). C=control untreated cells; N=20 ug/ml nephrilin peptide. *, **: p<0.05 and p<0.01 respectively, N versus C pairing; #, ##: p<0.05 and p<0.01 respectively, Cuv (or Cox) versus C pairing.
Figure 2Renal PTECs were grown and challenged with H2O2 (ox subscript) ± nicotine (Nic) and ROS generation measured as described in Methods. Values are averages of triplicate assays. C=control untreated cells; N=10 ug/ml nephrilin peptide; S=10 ug/ml scrambled peptide. *, **: p<0.05 and p<0.01 respectively, N (or S) versus C pairing; # = p<0.05 Cox versus C.
RNA arrays. RNAs were extracted from cells and analyzed on Agilent Rat Gene Expression Microarrays 4×44K (AMDID 014879) as described in Methods. Of 41,105 genes interrogated 49 upregulated (>3-fold threshhold) genes of known function for which treatment with H2O2 alone was >30% over control and treatment with the Nic+ H2O2 combination elevated expression an additional >30% were identified.
| ProbeName | GeneSymbol | GenbankAccession | GeneName | FOLD UPREG |
|---|---|---|---|---|
| A_44_P812665 | Mypn | NM_001107628 | myopalladin | 9.3 |
| A_42_P812805 | Smoc2 | NM_001106215 | SPARC related modular calcium binding 2 | 8.4 |
| A_44_P704258 | En2 | NM_001109214 | engrailed homeobox 2 | 8.2 |
| A_43_P12905 | Bik | NM_053704 | BCL2-interacting killer (apoptosis-inducing) | 8.2 |
| A_44_P288548 | Prex1 | NM_001135718 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 | 8.0 |
| A_44_P285988 | Chrdl2 | NM_001107537 | chordin-like 2 | 7.6 |
| A_44_P361951 | Adssl1 | XM_001072867 | adenylosuccinate synthase like 1 | 7.2 |
| A_44_P356161 | Ppy | NM_012626 | Pancreatic Polypeptide | 7.1 |
| A_43_P15474 | Spef2 | NM_022620 | sperm flagellar 2 | 6.9 |
| A_44_P572533 | Cabyr | NM_001143893 | calcium binding tyrosine-(Y)-phosphorylation regulated | 5.8 |
| A_44_P323349 | Gria4 | NM_017263 | glutamate receptor, ionotropic, AMPA 4 | 5.7 |
| A_42_P832832 | Ckm | NM_012530 | creatine kinase, muscle | 5.6 |
| A_44_P250467 | Cd22 | NM_001107503 | CD22 molecule | 5.2 |
| A_42_P536266 | Dnm3 | XM_006250137 | dynamin 3 | 5.2 |
| A_44_P258225 | Ly6h | NM_001134839 | lymphocyte antigen 6 complex, locus H | 5.2 |
| A_44_P414340 | Amelx | NM_019154 | amelogenin, X-linked | 5.0 |
| A_44_P208532 | ldo2 | XM_006222273 | indoleamine 2,3-dioxygenase 2 | 4.9 |
| A_44_P145562 | Dock2 | XM_001068649 | dedicator of cytokinesis 2 | 4.7 |
| A_43_P13056 | IllOra | NM_057193 | interleukin 10 receptor, alpha | 4.7 |
| A_44_P665425 | Rnfl65 | NM_001164505 | ring finger protein 165 | 4.5 |
| A_44_P762053 | Palld | XM_006253064 | palladin, cytoskeletal associated Protein | 4.4 |
| A_44_P104630 | Lat2 | NM_173840 | linker for activation of T cells family, member2 | 4.4 |
| A_44_P236523 | Hoxdl0 | NM_001107094 | homeo box D10 | 4.4 |
| A_44_P212521 | Gzmf | NM_153466 | granzyme F | 4.3 |
| A_44_P497282 | Rab11fip4 | NM_001107023 | RAB11 family interacting protein 4 (class II) | 4.3 |
| A_44_P416899 | Npy4r | NM_031581 | neuropeptide V receptor V4 | 4.3 |
| A_44_P1043302 | Crb3 | NM_001025661 | crumbs homolog 3 (Drosophila) | 4.3 |
| A_44_P1036769 | Matn1 | NM_001006979 | matrilin 1, cartilage matrix Protein | 4.2 |
| A_42_P841193 | Ddit4l | NM_080399 | DNA-damage-inducible transcript 4-like | 4.2 |
| A_44_P291071 | Rora | NM_001106834 | RAR-related orphan receptor A | 4.2 |
| A_43_P18101 | Eif3 | NM_001024768 | E74-like factor 3 | 4.1 |
| A_42_P525876 | Erg | NM_133397 | v-ets avian erythroblastosis virus E26 oncogene | 4.0 |
| A_44_P372305 | Syn3 | NM_017109 | synapsin 111 | 3.9 |
| A_43_P19535 | Mrgprb4 | NM_001002287 | MAS-related GPR, member B4 | 3.9 |
| A_44_P520521 | Slcl7a2 | NM_001107353 | solute carrier family 17, member 2 | 3.8 |
| A_44_P1001317 | Nabp1 | NM_001014216 | nucleic acid binding protein 1 | 3.8 |
| A_44_P555417 | Hoga1 | NM_001106355 | 4-hydroxy-2-oxoglutarate aldolase 1 | 3.7 |
| A_44_P147156 | Rbm47 | NM_001005882 | RNA binding motif protein 47 | 3.7 |
| A_44_P199028 | Dkk1 | NM_001106350 | dickkopf WNT signaling Pathway inhibitor 1 | 3.5 |
| A_44_P144788 | Mtmr12 | XM_006232046 | myotubularin related protein 12 | 3.5 |
| A_43_P18793 | Gfpt2 | NM_001002819 | glutamine-fructose-6-phosphate transaminase 2 | 3.4 |
| A_44_P485948 | Cux2 | NM_001271380 | cut-like homeobox 2 | 3.3 |
| A_44_P491864 | Fgfl4 | XM_006252526 | fibroblast growth factor 14 | 3.1 |
| A_44_P1020482 | Nalcn | NM_153630 | sodium leak channel, non-selective | 3.0 |
| A_42_P601961 | Susd3 | NM_001107341 | sushi domain containing 3 | 3.0 |
| A_44_P318628 | Chrnb2 | NM_019297 | cholinergic receptor, nicotinic, beta 2 (neuronal) | 3.0 |
| A_44_P1035007 | Chrne | NM_017194 | cholinergic receptor, nicotinic, epsilon (muscle) | 3.0 |
| A_44_P178498 | B3galt5 | NM_001105887 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, Polypeptide 5 | 3.0 |
| A_44_P1048543 | Ghrh | NM_031577 | growth hormone releasing hormone | 3.0 |
Figure 3Pathway analysis using Ingenuity Systems software. Major network (score=32) is shown. Dataset was 3057 genes exhibiting differential expression in the Agilent RNA arrays (see text).
Figure 4Kidney tissue extracts were prepared and analyzed by ELISA as described in Methods. S=sham group; B=burn+saline; N1=burn+4mg/kg/day SQ nephrilin for 1 week post-burn. **p<0.01, N1 versus B; #, ##: p<0.05 and p<0.01, B versus S.
Abbreviation: AU, arbitrary units.
Figure 5All extracts were prepared and assays performed as described in Methods. (A) Urine samples were assayed by ELISA and standardized against Cystatin C. (B) Gene transcripts were standardized versus GAPDH as standard. (C) Histone-3 phosphorylation and acetylation, as well as total histone-3, were determined by ELISA. Kidney tissues from 6 (B6=B group 6 hr) and 24 hours (S24, B24, N24) post-burn were assayed for phosphorylation, as early event. (D) CpG methylation is expressed in arbitrary units; each bar is an average of 4 animals. S=sham group; B=burn+saline; N1=burn+4mg/kg/day SQ nephrilin for 1 week post-burn. *p<0.05, N1 versus B; # p<0.05, B versus S.